Two stocks keep showing up in the same conversation right now, for the same reason. Every AI accelerator needs a brain and it needs memory. ARM licenses the architecture behind the brain. Micron makes the memory. Both are proxies for the same underlying question the market can't stop arguing about: does the agentic AI buildout keep consuming compute at this pace, or does 2026 turn out to be the top.

If you own either one, or you're deciding whether to start, this is the comparison that actually matters: not which company is better, but which one the market has already priced for the good outcome and which one it hasn't. Pull up both charts side by side and the picture is almost comic: one line grinding sideways off a spike, the other climbing a wall most investors are still too spooked to touch. Same skyline, two completely different weather systems.

Both stocks have already answered part of that question with a violent round trip. ARM fell 46% from its June high to roughly $199 in July, then nearly erased the entire drop on a single earnings beat. Micron is up more than 700% off its 2025 low and just crossed toward a trillion-dollar market cap. Same theme, same year, opposite valuation setups. That gap is the whole story.

The business each one actually runs

ARM doesn't build chips. It licenses the design and collects a royalty on every unit shipped, which is why gross margin barely matters to the thesis and unit volume does. Data center royalty revenue more than doubled year over year again last quarter, Arm-based compute now holds roughly 50% share with the major hyperscalers, and the new AGI CPU program has a customer pipeline that just doubled to more than $2 billion across fiscal 2027 and 2028. Total revenue grew 22% last quarter to a record $1.29 billion.

Micron makes the part that's actually gating AI buildouts right now: high bandwidth memory. HBM3E and HBM4 are sold out through 2027, with customers signing supply agreements up to five years out. Data center revenue grew more than 150% year over year last quarter, the fastest rate the company has ever recorded, and gross margin has expanded toward 86% as pricing power returns to a business that carried the stale, discounted smell of a commodity for most of the last decade.

Both stories are real. Neither is a rumor or a narrative stretch. The difference is what you're being asked to pay for each one.

What the market is charging you

ARM trades at 288x trailing earnings and 118x forward earnings, against a semiconductor sector average closer to 30x. The average analyst price target sits almost exactly at today's price, which tells you the sell side has already caught up to the story and priced it correctly. There is very little room in that multiple for a slow quarter.

Micron trades at 19.8x trailing earnings and just 6.1x forward earnings, despite the 700%+ run, versus a sector average near 27x. The market is still pricing Micron as if the memory cycle is about to do what memory cycles have always done: peak, then collapse. It has priced almost none of the "this time the demand driver is structural, not just another PC and phone replacement cycle" case.

That's the actual comparison. ARM is a great business trading at a rich multiple with a thin margin of safety. Micron is a great business trading at a cheap multiple because the market still doesn't trust the cycle.

The scenarios, with numbers

Five outcomes, roughly 12 to 18 months out, weighted by how likely each one feels from here. These aren't predictions. They're a way to see the shape of the risk before you size a position. Chew on the base case in each table before you let the super bull number pull your eye, that's the one doing the real work.

ARM ($284.57 today)

Probability-weighted expected return: roughly -2%.

Micron ($876.30 today)

Probability-weighted expected return: roughly -1.5%.

Same math, completely different risk

Line those two expected returns up and they look almost identical. That's misleading. The number that matters is the base case, not the average. ARM's base case is roughly flat because you're already paying for the good outcome. Micron's base case is positive even in a scenario where the memory cycle does exactly what skeptics expect, because the stock still isn't pricing full credit for the AI demand story.

Put another way: the same disappointing quarter does very different things to each stock. For ARM, a growth deceleration is a multiple problem on top of a business problem, because there's no valuation cushion left to absorb it. For Micron, a lot of the bad news is the reason the multiple is 6x in the first place. The downside case is already the consensus case. You can hear this exact argument on every earnings call this quarter, from Micron's HBM pricing questions to Arm's China royalty questions, before either company says a word.

I've been reading notes from an investor whose process I trust, and the pattern is instructive: adding to ARM as it retraced toward $200, and adding to Micron as it pulled back toward $700. Not because either dip changed the thesis. Because neither did. Buying the same structural story at a lower price than last week is a different decision than chasing it at a higher one, and it's the one variable in this whole framework you actually control. Direction is a guess. Entry price is a choice. That's the discipline that separates an investor doing the math from a crowd chasing the chart, and it's worth envying more than either stock's return.

What this means for how you size either one

If you own ARM, know exactly what you're holding: a phenomenal royalty business priced for flawless execution over the next two years. That's not a reason to sell it. It's a reason to size it like what it is, and to add on the pullbacks rather than the breakouts.

If you're building a position in Micron, you're being paid, in multiple terms, to sit through a memory cycle that hasn't rolled over yet and might not for a while given how tight HBM supply is running. The risk isn't invisible. It's the entire bear case, and it's already in the price.

Here's the one-sentence version to carry into Monday: ARM asks you to underwrite the next two years going right, Micron only asks you to underwrite the next two years not going as badly as the multiple already assumes. That's not a reason to go all in on either name. It's a reason to know exactly which kind of risk you're taking before you take it, and to size accordingly. I'll be marking both of these against what actually happens as they report next quarter, so file this one away and grip your own numbers, not mine.

This is not investment advice, and nothing here should be read as a recommendation to buy or sell either stock. The scenarios and price targets are illustrative, not predictions. Do your own research, size positions to your own risk tolerance, and talk to a licensed advisor before making any investment decision.

www.strategysprints.com

Happy hunting.

Simon & The Sprinters